PAO Group, Inc. (OTCPK: PAOG)
Health Care · Pharmaceuticals · US
$0.00
+50.00% today · +50.0% 1Y
PAO Group, Inc. (OTCPK: PAOG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $573.05K and employs 7 people.
Over the last twelve months the share price has gained 50.0%, trading between 0.00 and 0.00.
PAOG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $573.05K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -56.69
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.91B
- Employees
- 7
- Next earnings
- —
About PAO Group, Inc.
Headquartered in Sandusky, Ohio, PAO Group, Inc. specializes in providing alternative patient care solutions. Through its subsidiaries, the company is actively engaged in the development, distribution, and sale of high-quality medicinal cannabis products, specifically designed to support individuals with chronic and terminal conditions.
- ISIN
- US6986681004
- Listed since
- Sep 8, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.